Clarapath, a White Plains, NY-based medical robotics firm modernizing and reworking how pathology laboratories course of tissue, raised $36m in Sequence B-1 funding.
The spherical was led by Northwell Ventures with participation from CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures.
The corporate intends to make use of the funds to additional speed up the commercialization of SectionStar™, to develop its gross sales and repair, precision manufacturing capabilities in addition to proceed its R&D pipeline.
Led by Eric Feinstein, CEO, Clarapath is a medical robotics firm geared toward catalyzing change in the way in which pathology laboratories work. Its SectionStar is a (pending US launch) all-in-one tissue sectioning and switch system that will increase capability, reliability, and consistency whereas minimizing the necessity for extremely expert labor. The corporate is headquartered and runs its medical system improvement in Hawthorne, NY. It has a CLIA-certified laboratory that serves scientific and non-clinical organizations.
FinSMEs
24/07/2024
